
To learn more about Sanofi's Sarclisa, click here.
With many chemo and ADHD drugs stuck in stubborn shortages, several agencies are looking for new solutions to boost supplies.Details >In an ambitious effort to address the ongoing uncertainty within the 340B Program space, 6 senators released a draft discussion bill earlier this year titled the SUSTAIN Act.Details >
• Astellas XTANDI Support Solutions • Boehringer Ingelheim Cares Foundation • Deciphera Access Point Details >
No new, retired, and revised policies/articlesDetails >• J0881 and J0885 Coverage & Billing Requirements • Providers Inappropriately Deactivated • Targeted Probe & Educate Problem Error Rates • Updated Medicare Hot Links Details >New training opportunities availableDetails >
Recent Oncology Related Articles• New CMS Guidance • Part B Drug Payment Limits Overview • HHS Final Rule Clarifying the Eligibility of DACA • MLN Matters • And More Details >This edition includes articles on• Discharge Appeals to be Rerouted by Kepro • Malice or Stupidity • Coverage Expanded to DACA Recipients • Efficient, Effective Patient Access Operations Details >
Recent Oncology Related News• BCBSM Carelon Authorization Letter Revised! Details >Publications• The Record • BCN Provider News Details >
Last Reviewed/Updated 5-14-24• New! 0885 Claims Denied • New! Procrit Denials (693) • Procrit or Epoetin Class Drugs Maintenance • And More Details >Last Reviewed/Updated 5-14-24• BCBSM Carelon Letter • BCBSM Reimbursement on MVASI Details >• Site of Care for Specialty Drugs • Submitting Precertification Request • April Newsletter Details >• Two Midnight Rule Clarification • Keep Provider Information Updated in NPPES • Prior Auth & Benefit Coverage Policy Updates Details >• Beneficiary Co-Payment Requirements • MMP Bulletins • Biller "B" Aware Notices Details >• Evolent Oncology Prior Auth Changes • FAQ: Evolent Quality Management Program • Clinical & Payment Policies • Change Healthcare Connection FAQ Details >• Medicaid Claims Being Rejected Incorrectly • Formulary Changes Coming July 1 • PriceMyMeds Launched on April 25 • Provider Enrolled in Multiple ACN Contracts • And More Details >• Reimbursement Policy Updates • Medical Policy Updates • Medical Benefit Drug Policy Updates Details >
• Genentech Alecensa • Johnson & Johnson Carvykti • SeaGen & Genmab Tivdak Details > • Explore Updated Results From AstraZeneca's TOPAZ-1 Study Details >
May 2024 Frequently Asked Questions• EFT for CHAMPVA • Billing Incident-To Services • How Does NCCI Impact Coding? • Code 88342 Details >
|